首页 | 本学科首页   官方微博 | 高级检索  
     

终末期肾脏病患者冠状动脉钙化评估方法与心血管事件的关系
引用本文:谢应业,钟浩文,陈丽,章梦璧,谢娜,陈建华,刘玉峰,赖艳红,苏晓燕. 终末期肾脏病患者冠状动脉钙化评估方法与心血管事件的关系[J]. 国际医药卫生导报, 2022, 28(8): 1042-1046. DOI: 10.3760/cma.j.issn.1007-1245.2022.08.002
作者姓名:谢应业  钟浩文  陈丽  章梦璧  谢娜  陈建华  刘玉峰  赖艳红  苏晓燕
作者单位:中山大学附属东华医院肾内科,东莞 523000
基金项目:广东省基础与应用基础研究基金项目区域联合基金重点项目(2020B1515120037);东莞市社会科技发展重点项目(2018507150461629);东莞市社会科技发展一般项目(2018507150461232)
摘    要:目的:分析终末期肾脏病(ESRD)患者冠状动脉钙化(CAC)及其评估方法与主要心血管不良事件(MACE)的关系。方法:选取2018年5月至2020年10月在中山大学附属东华医院确诊为ESRD患者共228例,分析ESRD患者合并CAC的病例特点,并通过logistic回归法分析CAC评估方法CT重建技术中Agatston...

关 键 词:终末期肾脏病  冠状动脉钙化  钙化积分  主要不良心血管事件  危险因素
收稿时间:2021-11-25

Assessment of coronary artery calcification and its relationship with cardiovascular events in patients with end-stage renal diseases
Xie Yingye,Zhong Haowen,Chen Li,Zhang Mengbi,Xie Na,Chen Jianhua,Liu Yufeng,Lai Yanhong,Su Xiaoyan. Assessment of coronary artery calcification and its relationship with cardiovascular events in patients with end-stage renal diseases[J]. International Medicine & Health Guidance News, 2022, 28(8): 1042-1046. DOI: 10.3760/cma.j.issn.1007-1245.2022.08.002
Authors:Xie Yingye  Zhong Haowen  Chen Li  Zhang Mengbi  Xie Na  Chen Jianhua  Liu Yufeng  Lai Yanhong  Su Xiaoyan
Affiliation:Department of Nephrology, TungWah Hospital of Sun Yat-sen University,Dongguan 523000, China
Abstract:Objective To analyze theassessment method of coronary artery calcification (CAC) in patients withend-stage renal diseases (ESRD) and its relationship with major adversecardiovascular events (MACE). Methods From May 2018 to October 2020, 228 patients with ESRD from TungWahHospital of Sun Yat-sen University were enrolled. The clinical characteristicsof ESRD patients with CAC were analyzed. Logistic regression analysis was usedto evaluate the assessment and forecast the efficiencies of CAC integral [Agatston(AS) integral, volume integral (VS integral), and mass integral (MS integral)]in CT reconstruction technique for the occurrence of MACE in the ESRD patients.Independent sample t test was usedfor inter-group comparison of the measurement data conforming to normaldistribution, rank sum test was used for inter-group comparison of themeasurement data conforming to abnormal distribution, and χ2 test was used for inter-group comparison of the countdata. Results According to the occurrence of CAC, the ESRD patients were dividedinto a CAC group [164 cases, 108 males and 56 females, aged 61.00 (50.00,71.00) years] and a non-CAC group [64 cases, 43 males and 21 females, aged38.00 (31.00, 45.00) years]. The incidence of MACE in the CAC group was significantlyhigher than that in the non-CAC group [60.98% (100/164) vs. 21.87% (14/64)],with a statistically significant difference (P<0.001). In the CAC group, the three CAC integrals of the MACEsubgroup were significantly higher than those of the non-MACE subgroup (ASintegral: 4 267.0 vs. 725.3, P<0.001;MS integral: 3.2 vs. 2.7, P<0.001;VS integral: 4 732.0 vs. 881.9, P<0.001).Logistic regression analysis showed that AS integral, MS integral, VS integral,and albumin were all risk factors for MACE in the ESRD patients, among which MSintegral and albumin were independent risk factors for MACE in the ESRDpatients (all P<0.05). Conclusions ESRD patients with CAC have a high incidence of MACE. MS integral isan independent risk factor of MACE occurrence in ESRD patients, and might beapplied to clinical monitoring of the occurrence and development of MACE inESRD patients.
Keywords:End-stage renal diseases  Coronary artery calcification  Calcification integral  Major adverse cardiovascular events  Risk factors
本文献已被 万方数据 等数据库收录!
点击此处可从《国际医药卫生导报》浏览原始摘要信息
点击此处可从《国际医药卫生导报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号